(Q44112212)

29 November 2017

title

Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study (English)

1 reference

Cesar Alejandro Arce Salinas

29 November 2017

1 reference

1

object named as

C. A. Arce-Salinas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655489

21 July 2024

author name string

A. R. Villa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655489

21 July 2024

J. O. Martínez-Rueda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655489

21 July 2024

L. Muñoz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655489

21 July 2024

M. H. Cardiel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655489

21 July 2024

J. Alcocer-Varela

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655489

21 July 2024

D. Alarcón-Segovia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655489

21 July 2024

language of work or name

1 reference

1 June 1995

1 reference

full work available at URL

29 November 2017

http://journals.sagepub.com/doi/pdf/10.1177/096120339500400306

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

21 July 2024

1 reference

29 November 2017

volume

4

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

197-203

1 reference

Estimating prognosis in systemic lupus erythematosus

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

End-stage renal disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

The clinical course of the proliferative and membranous forms of lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Cyclophosphamide in lupus nephritis: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Prognostic factors in lupus nephritis. Contribution of renal histologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Lupus nephritis: correlation of interstitial cells with glomerular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

NIH conference. Lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Mortality in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Approaches to sample size estimation in the design of clinical trials--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Immunosuppressive drug therapy in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

A critique of the NIH lupus nephritis survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Cytotoxic drugs: their clinical application to the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Azathioprine, cyclophosphamide and chlorambucil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Variables associated with decreased survival in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

The progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

Immunologic factors and clinical activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339500400306

The natural history of systemic lupus erythematosus by prospective analysis

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

21 July 2024

3

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Why do patients with lupus nephritis die?

21 July 2024

4

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

21 July 2024

8

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

21 July 2024

10

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Treatment of Lupus Nephritis With Azathioprine

21 July 2024

11

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine

21 July 2024

13

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months

21 July 2024

14

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

21 July 2024

17

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

21 July 2024

18

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

The Quarterly Journal of Medicine

21 July 2024

21

72

779

Esdaile JM

1989

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Correlation of renal histology with outcome in children with lupus nephritis

21 July 2024

23

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

21 July 2024

26

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

21 July 2024

28

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

21 July 2024

30

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus

21 July 2024

31

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

21 July 2024

32

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Observer agreement in the scoring of the activity and chronicity indexes of lupus nephritis

21 July 2024

33

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center

21 July 2024

34

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980

21 July 2024

37

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results

21 July 2024

38

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)

21 July 2024

39

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Therapeutic trials in lupus nephritis. Problems related to renal histology, monitoring of therapy and measures of outcome

21 July 2024

40

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

21 July 2024

42

51

484

Donadio JV

1976

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients

21 July 2024

44

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

The Journal of Rheumatology

21 July 2024

53

20

1694

Ginzler EM

1993

1 reference

https://api.crossref.org/works/10.1177/096120339500400306

21 July 2024

Identifiers

1 reference

29 November 2017

1 reference